Navigation Links
Multidisciplinary meeting on urological cancers aims to benefit cancer patients
Date:11/19/2009

Arnhem, November 2009 -- Experts agree that the urological cancer patient will benefit greatly if the delivered treatment is the result of a combined effort. Collaboration of experts from various fields is, therefore, necessary to take cancer-related research and medical practice to the next level. The 2nd European Multidisciplinary Meeting on Urological Cancers (EMUC) Embracing Excellence in Prostate, Bladder and Kidney Cancer - which is to take place on 27-29 November 2009 in Barcelona (ES), brings together urologists, radiologists and medical oncologists by enabling them to share their knowledge and experience. The meeting is organised by the European Association of Urology (EAU), the European Society for Medical Oncology (ESMO) and the European Society for Therapeutic Radiology and Oncology (ESTRO) and was first held two years ago.

With the objective to facilitate multidisciplinary approaches that aim to optimise diagnostic, therapeutic and preventional interventions directed towards malignant disorders in the urogenital tract, the 2nd EMUC Meeting will feature presentations on the latest research from selected, translational and clinical abstracts, as well as related scientific and educational sessions.

"Meetings such as these are of great significance in promoting further scientific collaboration, not just on an international level, but even more so between the various experts working in the challenging and fast evolving fields of prostate, bladder and renal cell cancer", says Prof. Per-Anders Abrahamsson from Malm (SE), member of the EMUC Organising Steering Committee on behalf of the EAU.

Screening for prostate cancer, a much debated subject with far-reaching consequences, is one of the interesting issues on the meeting's agenda. According to Prof. Jos Baselga, Barcelona (ES), member of the EMUC Organising Steering Committee on behalf of the ESMO: "New compounds for the treatments of castrate-resistant prostate cancer and advanced renal cell carcinoma will be discussed. Furthermore, subjects such as urine markers in the screening of bladder cancer and new systemic treatment modalities in advanced bladder cancer are highlighted in State-of-the-art lectures and debates during the meeting".

The meeting enables experts to present the most recent advances in prostate, bladder and renal cell cancer and spans the entire field; from bench research to clinical applications which should be of interest to both clinicians and basic scientists. The future of European (and worldwide) urological cancer research will largely depend on advances in these fields.

"The involvement of world experts in their fields, the broad spectrum of topics discussed including biology, prevention, diagnosis, therapy and quality of life issues should guarantee comprehensive coverage", says Prof. Michael Baumann, Dresden (DE), member of the EMUC Organising Steering Committee on behalf of the ESTRO.

A multidisciplinary approach in urooncological patient care will eventually become an essential part of routine health care. For that reason, collaboration between academia, health care providers in general, but especially among urologists, radiation oncologists and medical oncologists will be the future.

Barcelona with its many cultural and culinary wonders will be an entertaining and interesting backdrop for this meeting.


'/>"/>

Contact: Lindy Brouwer
l.brouwer@uroweb.org
European Association of Urology
Source:Eurekalert

Related medicine news :

1. Mayo Clinic Multidisciplinary Simulation Center Receives Distinction as an ACS-Accredited Education Institute
2. SAGE launching new sports medicine journal in 2009: Sports Health: A Multidisciplinary Approach
3. APTAs Multidisciplinary Summit Establishes Opportunities for Physical Therapists to Drive Health Care Change
4. Elsevier Launches SciVal Spotlight: New Tool Provides Multidisciplinary View of Research Performance
5. ECCO 15 -- ESMO 34 multidisciplinary cancer congress
6. Media registration for ECCO 15 -- ESMO 34 multidisciplinary cancer congress
7. Bayer and Onyx Announce Nexavar Data Presentations at the Joint 15th European CanCer Organisation (ECCO) and 34th European Society for Medical Oncology (ESMO) Multidisciplinary Congress
8. Mastery of Myeloma Continuing Education Training Program for the Multidisciplinary Care Team Set for Western Region
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
11. Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in ... America . ... ... ... ...
(Date:6/23/2016)... FRANKLIN, Tenn. , June 23, 2016 ... for automating, integrating and transforming the patient ... launch of several innovative new products and ... depth of its revenue cycle offerings. These ... establish more efficient workflows, remain compliant in ...
Breaking Medicine Technology: